3 hours Q32 Bio (NASDAQ:QTTB) Receives New Coverage from Analysts at Raymond JamesMarketBeat
Raymond James started coverage on Q32 Bio in a research note on Thursday. They set a “strong-buy” rating and a $90.00 price objective for the company.
XRaymond James started coverage on Q32 Bio in a research note on Thursday. They set a “strong-buy” rating and a $90.00 price objective for the company.
X